Ignite Creation Date:
2025-12-24 @ 10:50 PM
Ignite Modification Date:
2025-12-25 @ 8:20 PM
Study NCT ID:
NCT00074269
Status:
TERMINATED
Last Update Posted:
2023-06-05
First Post:
2003-12-10
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Allogeneic Stem Cell Transplant After ATG, High-Dose Melphalan, and Fludarabine for Patients With Breast Cancer
Sponsor:
University of California, San Diego
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-07
Start Date Type:
None
Primary Completion Date:
2008-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-03
Completion Date Type:
ACTUAL
First Submit Date:
2003-12-10
First Submit QC Date:
None
Study First Post Date:
2003-12-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-05-29
Results First Submit QC Date:
None
Results First Post Date:
2014-11-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-05-08
Last Update Post Date:
2023-06-05
Last Update Post Date Type:
ACTUAL